Verastem (VSTM) Gains from Investment Securities (2012 - 2026)

Verastem (VSTM) recorded quarterly Gains from Investment Securities of -$9.3 million in Q1 2026, up 75.33% quarter-over-quarter from -$37.8 million in Q4 2025, and down 485.89% on a YoY basis from $2.4 million in Q1 2025.

Verastem (VSTM) Gains from Investment Securities (2012 - 2026) Analysis & Trends

Verastem's Gains from Investment Securities history runs 15 years deep, the most recent figure standing at -$9.3 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities fell 485.89% year-over-year to -$9.3 million; the TTM figure through Mar 2026 stood at -$25.5 million (down 158.66% YoY), while the FY2025 annual figure was $3.0 million, up 22.24% from the prior year.
  • Gains from Investment Securities was -$9.3 million for Q1 2026 at Verastem, up from -$37.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $19.1 million in Q4 2024 to a low of -$37.8 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $302096.5 across 5 years, with a median of $603330.0 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Gains from Investment Securities soared 116910.5% in 2022, then tumbled 485.89% in 2026.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.2 million in 2022, then soared by 94.36% to $2.3 million in 2023, then soared by 743.43% to $19.1 million in 2024, then slumped by 297.36% to -$37.8 million in 2025, then soared by 75.33% to -$9.3 million in 2026.
  • The last three Gains from Investment Securities figures came in at -$9.3 million (Q1 2026), -$37.8 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.32 Mn
Mar 31, 2026 -9.32 Mn
Dec 31, 2025 -37.79 Mn
Dec 31, 2025 -37.79 Mn
Sep 30, 2025 1.13 Mn
Sep 30, 2025 1.13 Mn
Jun 30, 2025 554,500.00
Jun 30, 2025 554,500.00
Mar 31, 2025 2.42 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 19.15 Mn
Dec 31, 2024 19.15 Mn
Sep 30, 2024 13.50 Mn
Sep 30, 2024 13.50 Mn
Jun 30, 2024 184,122.00
Jun 30, 2024 184,122.00
Mar 31, 2024 603,330.00
Mar 31, 2024 603,330.00
Dec 31, 2023 2.27 Mn
Dec 31, 2023 2.27 Mn